Remove Global Remove Slovenia Remove Standards Remove Supplies
article thumbnail

Daimler and Geely Holding form global JV for smart; new generation of electric models

Green Car Congress

Daimler AG and Zhejiang Geely Holding Group , the German and Chinese automotive groups, have formed a 50-50 globally focused joint venture to own, operate and further develop smart, the pioneer of small urban vehicles, as a leader in premium-electrified vehicles. Future production will be located in China.

Global 259
article thumbnail

Mercedes-Benz will be producing 8 all-electric EQ models in 2022

Green Car Congress

In 2022, Mercedes-Benz’ global portfolio will include eight all-electric Mercedes-EQ models. The global Mercedes-Benz production network is ready for the company’s electric product offensive and is integrating its Mercedes-EQ models into series production in its existing plants. kWh/100 km) in Novo Mesto, Slovenia.

Mercedes 259
article thumbnail

Cooperation between Daimler and Renault-Nissan Alliance deepening in 2016

Green Car Congress

Launched in 2014, the smart two-seater is built at Daimler’s Hambach plant, France, whereas both four-seater vehicles are produced at Renault’s plant in Novo Mesto, Slovenia. A new quality evaluation standard will be implemented at the facility to assure the delivery of premium-model quality.

2016 218
article thumbnail

Drive Electric Submission on the Emissions Reduction Plan Discussion Document

Drive Electric

In New Zealand’s fight against climate change, e-mobility is a low-hanging fruit, especially given our supply of renewable energy. . The domestic OEM industry can think differently, and look to Europe (particularly the UK) for new and used supply. We also don’t need to ‘reinvent the wheel’. New Zealand receives less than 0.17

article thumbnail

A Smart Artificial Pancreas Could Conquer Diabetes

Cars That Think

The entire blood supply of a typical adult contains 4 or 5 grams of sugar—roughly as much as in the paper packet that restaurants offer with coffee. The six-month trial tested Control-IQ against the standard treatment, in which the patient does all the work, using information from a glucose monitor to operate an insulin pump.

Personal 144